top of page

Novo Holdings to acquire Altasciences

" Novo Holdings A/S, a world-leading life science investor with a focus on long-term, sustainable value creation, today announced that it has agreed to acquire Altasciences from Audax Private Equity."

"Founded in 1992, Altasciences is a leading, fully-integrated, early drug development services platform, providing the pharma and biotech industries with a trusted partner for drug development, from preclinical safety testing through clinical proof-of-concept studies. In the past decade, the company has grown both organically and through acquisitions to have a significant presence in the preclinical safety testing, clinical pharmacology, bioanalytical, CRO services, and CDMO markets. Headquartered in Laval, Canada, Altasciences operates six facilities in the U.S. and Canada and employs over 1,300 people."

"The company's full-service, integrated offering is uniquely tailored to the needs of small and medium-sized biopharma sponsors, which are expected to account for an increasing share of the growing pipeline of drugs in development. The acquisition by Novo Holdings will help Altasciences continue its impressive growth trajectory, including further domestic and international expansion..."

022212 Novo Holdings to acquire Altascie
Download • 32KB

bottom of page